51 - 75 of 71
Number of results to display per page
TitleCreatorRelation Is Part Of
51 MEK Inhibitor Treatment Promotes Retinal Ganglion Cell Preservation without Preventing Retrobulbar Demyelination in Neurofibromatosis MiceSteven Stasheff; Francisco Nadal-Nicolas; Wei Li; Miriam Bornhorst; Yuan ZhuNANOS 2019: Scientific Platform III
52 Pathological Processes of Eye Muscles (Video)Stacy Pineles, MD, MSNANOS Annual Meeting 2015 Mechanical Causes of Strabismum
53 Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study ResultsRaymond S, Douglas; Saba Sile; Terry J. Smith; George J. KahalyNANOS Annual Meeting 2021: Scientific Platform I
54 VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in PatientsRaymond Douglas; Kimberley Cockerham; Roger Turbin; Rosa Tang; Navdeep Nijhawan Shoaib Ugradar; Denis O'Shaughnessy; Rochelle Summerfelt; Angela She; Barrett KatzNANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/
55 Epigenetic Reprogramming- A Novel Gene Therapy to Rejuvenate Injury-Induced Dysfunction of Retinal Ganglion Cells in Optic NeuropathiesDrenushe Krasniqi; Madhura Shah; Margarete Karg; Yuancheng Lu; David Sinclair; Bruce Ksander; Joseph RizzoNANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/
56 Genotype-Phenotype Correlations in Autosomal Dominant Optic AtrophyJoshua Harvey; Eun Hee Hong; Gerard Smits; Neringa Jerkute; Gavin Arno; Victoria Nesbitt; Marcela Votruba; Patrick Yu-Wai-ManNANOS Annual Meeting 2022: Scientific Platform III
57 Increase ER Stress in Ischemic Optic Neuropathy: Implications in Diabetes and Effects of Insulin TreatmentYaping Joyce Liao; Varun Kumar; Louise Mesentier Louro; Kathleen Heng; Mohammed Shariati; Angela OhNANOS Annual Meeting 2018: Scientific Platform Presentations Session 2
58 Resveratrol Nanoparticles Are Neuroprotective in Experimental, Optic Neuritis (Video)Ehtesham Shamsher; Reas Khan; Kimberly Dine; Vy Luong; Benjamin Davis; Keirnan Willett; Satyanarayana Somavarapu; M. Francesca Cordeiro; Kenneth ShindlerNANOS Annual Meeting 2020: Scientific Platform Session I
59 Efficacy and Safety of Satralizumab from Two Phase 3 Trials in Neuromyelitis Optica Spectrum Disorder (Video)Benjamin Frishberg; Jerome de Seze; Brian Weinshenker; Yusuke Terada; Yuichi Kawata; Athos Gianella-Borradori; H. Christian von Büdingen; Gaelle Klingelschmitt; Anthony Traboulsee; Takashi YamamuraNANOS Annual Meeting 2020: Scientific Platform Session I
60 European Perspective - It Could Be MSAxel Petzold, MD, PhD, FRCP, FRCPath, FRCOphthNANOS Annual Meeting 2023: State of the Art - Global Perspectives: https://novel.utah.edu/collection/NAM/toc/
61 NMO: What You Need to Know (Video)Sashank PrasadNANOS Annual Meeting 2016: Hot Topics - Today and Tomorrow
62 Teprotumumab Effect on Proptosis, Diplopia and Quality of Life in Active Thyroid Eye Disease (TED) (Video)Jade Schiffman; Rosa Tang; George Kahaly; Terry Smith; Saba Sile; Elizabeth Thompson; Thomas Vescio; Jeffrey Sherman; Raymond DouglasNANOS Annual Meeting 2020: Scientific Platform Session I
63 Visual Snow Syndrome: Differential Diagnosis and WorkupMichael Vaphiades, DONANOS Annual Meeting 2023: Hot Topics: https://novel.utah.edu/collection/NAM/toc/
64 When to Suspect a Hereditary Condition?Dan Milea, MD, PhDNANOS Annual Meeting 2023: Neuro-Ophthalmic Genetics: When, How, In Whom, and Why to do Genetic Testing: https://novel.utah.edu/collection/NAM/toc/
65 The Diversity Benefit - NANOS Diversity Report (Telehealth: A Potential Solution to the Workforce and Diversity Problem or Not?)Kevin E. Lai, MDNANOS Annual Meeting 2023: The Future of NO - Diversity, Equity, and Inclusion: https://novel.utah.edu/collection/NAM/toc/
66 Efficacy of Chronic Immunotherapy for Myelin Oligodendrocyte Glycoprotein-IgG DiseaseJohn Chen; Collin McClelland; Eric Eggenberger; Alfonso Lopez Chiriboga; Victoria Pelak; Heather Moss; Aubrey Gilbert; Michael Lee; Marie Acierno; Muhammad Bhatti; Jiraporn Jitprapaikulsan; Gregory Van Stavern; Divyanshu Dubey; Andrew McKeon; Jeffrey Bennett; Sean Pittock; Eoin Flanagan; Ore-ofe Ade...NANOS 2019: Scientific Platform III
67 What is Glaucoma: Clinically, Functionally, and Pathologically? (Video)Carol A. Rasmussen, MS; Paul L. Kaufman, MD
68 Acute Therapeutic Options for CRAO: To TPA or Not?Oana M. Dumitrascu, MD, MSNANOS Annual Meeting 2023: Hot Topics: https://novel.utah.edu/collection/NAM/toc/
69 International Multicenter Retrospective Study on Maintenance Intravenous Immunoglobulin in Preventing Relapse in Adult MOG-Antibody-Associated DiseaseJohn Chen; Saif Huda; Yael Hacohen; Michael Levy; Itay Lotan; Adi Wilf-Yarkoni; Hadas Stiebel-Kalish; Mark Hellmann; Elias Sotirchos; Amanda Henderson; Sean Pittock; M. Tariq Bhatti; Eric Eggenberger; Marie DiNome; Ho Jin Kim; Albert Saiz; Friedemann Paul; Russell Dale; Sudarshini Ramanathan; Jacque...NANOS Annual Meeting 2022: Scientific Platform Session II
70 Pathogenic NR2F1 Variants Cause a Systemic Neurodevelopmental Ocular Phenotype Recapitulated in a Mutant Mouse ModelNeringa Jurkute; Michele Bertacchi; Gavin Arno; Chiara Tocco; Ungsoo Kim; Adam Kruszewski; Robert Avery; Emma Bedoukian; Jinu Han; Sung Ahn; James Acheson; Indran Davagnanam; Richard Bowman; Marios Kaliakatsos; Ashwin Reddy; Ngozi Oluonye; Patrizia Amati-Bonneau; Majida Charif; Guy Lenaers; Isabelle...NANOS Annual Meeting 2021: Scientific Platform I
71 NMO or NOT NMO, That Is the QuestionCarolyne Riehle, Emily Spoth, Jill Wilson, Bradley Katz, Meagan Seay, Sravanthi Vegunta, Judith Warner, Kathleen DigreNANOS Annual Meeting 2023: Walsh Society Meeting Session I: "Adventureland": Learning From Pediatric Neuro-Ophthalmic Disorders: https://novel.utah.edu/collection/NAM/toc/
51 - 75 of 71